Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. NanoRepro AG
  6. Summary
    NN6   DE0006577109

NANOREPRO AG

(NN6)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/22/2021 09/23/2021 09/24/2021 09/27/2021 09/28/2021 Date
9.02(c) 8.69(c) 8.83(c) 9.12(c) 8.68 Last
31 684 70 179 42 673 33 534 408 695 Volume
+0.22% -3.66% +1.61% +3.28% -4.82% Change
More quotes
Estimated financial data (e)
Sales 2019 1,81 M 2,11 M 2,11 M
Net income 2019 -1,19 M -1,39 M -1,39 M
Net cash position 2019 0,54 M 0,63 M 0,63 M
P/E ratio 2019 -5,03x
Yield 2019 -
Sales 2020 16,9 M 19,8 M 19,8 M
Net income 2020 1,69 M 1,98 M 1,98 M
Net Debt 2020 0,19 M 0,22 M 0,22 M
P/E ratio 2020 20,7x
Yield 2020 -
Capitalization 118 M 138 M 137 M
EV / Sales 2019 3,01x
EV / Sales 2020 2,08x
Nbr of Employees 14
Free-Float 52,5%
More Financials
Company
Nanorepro AG is a Germany-based company active in the biotechnology sector. The Company is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patientsÔÇÖ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as... 
More about the company
All news about NANOREPRO AG
09/23NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2021
CI
06/30NANOREPRO : Germany Medical Test Kit Maker Eyes SADC Market
AQ
06/14NANOREPRO : Secures CE Mark on Two SARS-CoV-2 Tests
MT
05/21Nanorepro Ag Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2020DGAP-DD : NanoRepro AG english
DJ
2020DGAP-DD : NanoRepro AG english
DJ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2020NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2019NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
2018NANOREPRO AG : Notification and public disclosure of transactions by persons
EQ
More news
News in other languages on NANOREPRO AG
06:15aNANOREPRO : und Viromed bauen Partnerschaft aus und vermarkten gemeinsam neues Echtzeit-PC..
06:15aNanoRepro AG und Viromed bauen Partnerschaft aus und vermarkten gemeinsam neues Echtzei..
06:15aNanoRepro AG und Viromed bauen Partnerschaft aus und vermarkten gemeinsam neues Echtzei..
09/23NANOREPRO AG : Exponentielles Wachstum im 1. Halbjahr 2021
09/23NANOREPRO AG : Exponentielles Wachstum im 1. Halbjahr 2021
More news
Chart NANOREPRO AG
Duration : Period :
NanoRepro AG Technical Analysis Chart | NN6 | DE0006577109 | MarketScreener
Technical analysis trends NANOREPRO AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers and Directors
Lisa JŘngst Chief Executive Officer
Michael Fuchs CFO, Investor & Press Relations Contact
Olaf Stiller Chairman-Supervisory Board
Michael J. Tillman Deputy Chairman-Supervisory Board
Bhuwnesh Agrawal Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
NANOREPRO AG142.55%138
SARTORIUS AG86.09%47 707
BIOTAGE AB (PUBL)73.81%1 810
REVENIO GROUP OYJ10.74%1 731
CELLAVISION AB (PUBL)32.77%1 117
VAREX IMAGING CORPORATION67.27%1 100